Page last updated: 2024-08-24

cilazapril, anhydrous and Kidney Diseases

cilazapril, anhydrous has been researched along with Kidney Diseases in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19904 (44.44)18.7374
1990's1 (11.11)18.2507
2000's4 (44.44)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Knap, N; Larczynski, W; Neuwelt, A; Renke, M; Rutkowski, B; Rutkowski, P; Tylicki, L; Wozniak, M1
Aleksandrowicz, E; LarczyƄski, W; Lysiak-Szydlowska, W; Renke, M; Rutkowski, B; Rutkowski, P; Tylicki, L2
Chen, YM; Chiang, WC; Chien, CT; Lin, SL; Tsai, CC; Tsai, TJ1
Abe, K; Kanazawa, M; Kohzuki, M; Sato, T; Yasujima, M; Yoshida, K1
Gotoh, E; Kaneko, Y; Shionoiri, H; Takagi, N; Takeda, K; Yabana, M1
Gotoh, E; Ishii, M; Minamisawa, K; Shionoiri, H; Sugimoto, K; Takasaki, I1
Carlsen, JE; Hansen, FM; Jensen, HA1
Bailey, RR; Swainson, CP; Walker, RJ1

Trials

3 trial(s) available for cilazapril, anhydrous and Kidney Diseases

ArticleYear
Spironolactone attenuates oxidative stress in patients with chronic kidney disease.
    Hypertension (Dallas, Tex. : 1979), 2008, Volume: 52, Issue:5

    Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Benzimidazoles; Benzoates; Chronic Disease; Cilazapril; Creatinine; Cross-Over Studies; Dinoprost; Diuretics; Female; Humans; Hydrochlorothiazide; Kidney Diseases; Male; Mineralocorticoid Receptor Antagonists; Oxidative Stress; Spironolactone; Telmisartan

2008
Dual blockade of the renin-angiotensin-aldosterone system with high-dose angiotensin-converting enzyme inhibitor for nephroprotection: an open, controlled, randomized study.
    Scandinavian journal of urology and nephrology, 2008, Volume: 42, Issue:4

    Topics: Acetylglucosaminidase; Adolescent; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Cilazapril; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fibrosis; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Peptide Fragments; Procollagen; Proteinuria; Renin; Renin-Angiotensin System; Telmisartan; Young Adult

2008
Triple pharmacological blockade of the renin-angiotensin-aldosterone system in nondiabetic CKD: an open-label crossover randomized controlled trial.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2008, Volume: 52, Issue:3

    Topics: Acetylglucosaminidase; Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Chronic Disease; Cilazapril; Collagen Type III; Cross-Over Studies; Disease Progression; Diuretics; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Kidney Diseases; Male; Mineralocorticoid Receptor Antagonists; Potassium; Proteinuria; Renin-Angiotensin System; Spironolactone; Telmisartan

2008

Other Studies

6 other study(ies) available for cilazapril, anhydrous and Kidney Diseases

ArticleYear
Pentoxifylline attenuated the renal disease progression in rats with remnant kidney.
    Journal of the American Society of Nephrology : JASN, 2002, Volume: 13, Issue:12

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cell Division; Cells, Cultured; Chemokine CCL2; Cilazapril; Disease Progression; Down-Regulation; Fibroblasts; Fibrosis; Gene Expression; Glomerular Mesangium; Kidney; Kidney Diseases; Male; Mitosis; Muscle, Smooth; Nephrectomy; Nephritis; Pentoxifylline; Phosphodiesterase Inhibitors; Rats; Rats, Wistar

2002
Do kinins mediate cardioprotective and renoprotective effects of cilazapril in spontaneously hypertensive rats with renal ablation?
    Clinical and experimental pharmacology & physiology. Supplement, 1995, Volume: 22, Issue:1

    Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Cilazapril; Heart Diseases; Kidney; Kidney Diseases; Kidney Failure, Chronic; Kidney Function Tests; Kinins; Nephrectomy; Organ Size; Rats; Rats, Inbred SHR

1995
Antihypertensive effects and pharmacokinetics of single and consecutive doses of cilazapril in hypertensive patients with normal and impaired renal function.
    Journal of cardiovascular pharmacology, 1988, Volume: 11, Issue:2

    Topics: Administration, Oral; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cilazapril; Creatinine; Female; Humans; Hypertension; Kidney Diseases; Male; Middle Aged; Peptidyl-Dipeptidase A; Pulse; Pyridazines

1988
Antihypertensive effects and pharmacokinetics of single and consecutive doses of cilazapril in hypertensive patients with normal or impaired renal function.
    British journal of clinical pharmacology, 1989, Volume: 27 Suppl 2

    Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cilazapril; Heart Rate; Humans; Hypertension; Kidney Diseases; Pyridazines

1989
Efficacy and safety of cilazapril in hypertensive patients with moderate to severe renal impairment.
    The American journal of medicine, 1989, Dec-26, Volume: 87, Issue:6B

    Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cilazapril; Creatinine; Female; Humans; Hypertension; Kidney Diseases; Male; Middle Aged; Placebos; Posture; Pyridazines; Single-Blind Method

1989
Effects of cilazapril on renal function and hormones in hypertensive patients with renal disease.
    The American journal of medicine, 1989, Dec-26, Volume: 87, Issue:6B

    Topics: Adult; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cilazapril; Female; Glomerular Filtration Rate; Humans; Hypertension; Kidney; Kidney Diseases; Male; Middle Aged; Pyridazines; Renal Circulation; Renin

1989